Literature DB >> 21149633

Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts.

Sharon Avery1, Weiji Shi, Marissa Lubin, Anne Marie Gonzales, Glenn Heller, Hugo Castro-Malaspina, Sergio Giralt, Nancy A Kernan, Andromachi Scaradavou, Juliet N Barker.   

Abstract

The influence of cell dose and human leukocyte antigen (HLA) match on double-unit cord blood (CB) engraftment is not established. Therefore, we analyzed the impact of cell dose and high-resolution HLA match on neutrophil engraftment in 84 double-unit CB transplant recipients. The 94% sustained engraftment rate was accounted for by 1 unit in nearly all patients. Higher CD3(+) cell doses (P = .04) and percentage of CD34(+) cell viability (P = .008) were associated with unit dominance. After myeloablative conditioning, higher dominant unit total nucleated cell (TNC), CD34(+) cell, and colony-forming unit doses were associated with higher sustained engraftment and faster neutrophil recovery (P = .07, P = .0008, and P < .0001, respectively). Total infused TNC (P = .0007) and CD3(+) cell doses (P = .001) also significantly influenced engraftment. At high-resolution extensive donor-recipient HLA disparity was frequent, but had no influence on engraftment (P = .66), or unit dominance (P = .13). Although the unit-unit HLA match also did not affect sustained engraftment (P = 1.0), recipients of units closely (7-10 to 10-10) HLA-matched to each other were more likely to demonstrate initial engraftment of both units (P < .0001). Our findings have important implications for unit selection and provide further insight into double-unit biology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21149633      PMCID: PMC3069669          DOI: 10.1182/blood-2010-08-300491

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity.

Authors:  A R Migliaccio; J W Adamson; C E Stevens; N L Dobrila; C M Carrier; P Rubinstein
Journal:  Blood       Date:  2000-10-15       Impact factor: 22.113

2.  High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome.

Authors:  G Kögler; J Enczmann; V Rocha; E Gluckman; P Wernet
Journal:  Bone Marrow Transplant       Date:  2005-12       Impact factor: 5.483

3.  Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group.

Authors:  E Gluckman; V Rocha; A Boyer-Chammard; F Locatelli; W Arcese; R Pasquini; J Ortega; G Souillet; E Ferreira; J P Laporte; M Fernandez; C Chastang
Journal:  N Engl J Med       Date:  1997-08-07       Impact factor: 91.245

4.  Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.

Authors:  P Rubinstein; L Dobrila; R E Rosenfield; J W Adamson; G Migliaccio; A R Migliaccio; P E Taylor; C E Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

5.  Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.

Authors:  Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; Bruce R Blazar; Jeffrey S Miller; John E Wagner
Journal:  Blood       Date:  2003-05-08       Impact factor: 22.113

6.  Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

Authors:  John E Wagner; Juliet N Barker; Todd E DeFor; K Scott Baker; Bruce R Blazar; Cindy Eide; Anne Goldman; John Kersey; William Krivit; Margaret L MacMillan; Paul J Orchard; Charles Peters; Daniel J Weisdorf; Norma K C Ramsay; Stella M Davies
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

7.  A scheme for defining cause of death and its application in the T cell depletion trial.

Authors:  Edward Copelan; James T Casper; Shelly L Carter; Jo-Anne H van Burik; David Hurd; Adam M Mendizabal; John E Wagner; Saul Yanovich; Nancy A Kernan
Journal:  Biol Blood Marrow Transplant       Date:  2007-12       Impact factor: 5.742

8.  Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy.

Authors:  Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; Bruce R Blazar; Philip B McGlave; Jeffrey S Miller; Catherine M Verfaillie; John E Wagner
Journal:  Blood       Date:  2004-10-05       Impact factor: 22.113

9.  Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow.

Authors:  J H Dalle; M Duval; A Moghrabi; E Wagner; M F Vachon; S Barrette; M Bernstein; J Champagne; M David; J Demers; P Rousseau; R Winikoff; M A Champagne
Journal:  Bone Marrow Transplant       Date:  2004-03       Impact factor: 5.483

10.  Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow.

Authors:  Juliet N Barker; Timothy P Krepski; Todd E DeFor; Stella M Davies; John E Wagner; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2002       Impact factor: 5.742

View more
  52 in total

Review 1.  Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine.

Authors:  Patricia Flores-Guzmán; Verónica Fernández-Sánchez; Hector Mayani
Journal:  Stem Cells Transl Med       Date:  2013-10-07       Impact factor: 6.940

2.  Cord blood unit factors influencing transplant outcomes from the Asian multiethnic Singapore Cord Blood Bank.

Authors:  S-Y Ong; C Phipps; P Chu; A Prasath; A Y L Ho; S J Sobak; W Hwang
Journal:  Bone Marrow Transplant       Date:  2015-06-08       Impact factor: 5.483

3.  Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match.

Authors:  D M Ponce; A Gonzales; M Lubin; H Castro-Malaspina; S Giralt; J D Goldberg; A M Hanash; A Jakubowski; R Jenq; E B Papadopoulos; M A Perales; M R M van den Brink; J W Young; F Boulad; R J O'Reilly; S Prockop; T N Small; A Scaradavou; N A Kernan; C E Stevens; J N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2013-02-14       Impact factor: 5.742

4.  Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation.

Authors:  Corey Cutler; Haesook T Kim; Lixian Sun; Doreen Sese; Brett Glotzbecker; Philippe Armand; John Koreth; Vincent Ho; Edwin Alyea; Karen Ballen; Jerome Ritz; Robert J Soiffer; Edgar Milford; Joseph H Antin
Journal:  Blood       Date:  2011-09-22       Impact factor: 22.113

5.  Optimizing selection of double cord blood units for transplantation of adult patients with malignant diseases.

Authors:  Giancarlo Fatobene; Fernanda Volt; Frederico Moreira; Lívia Mariano; Patrice Chevallier; Sabine Furst; Hélène Labussière-Wallet; Régis Peffault de la Tour; Eric Deconinck; Thomas Cluzeau; Nigel Russell; Dimitrios Karakasis; Edouard Forcade; Annalisa Ruggeri; Eliane Gluckman; Vanderson Rocha
Journal:  Blood Adv       Date:  2020-12-22

6.  Lineage relationships of human interleukin-22-producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cells.

Authors:  Yong-Oon Ahn; Bruce R Blazar; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2013-01-17       Impact factor: 22.113

7.  Early peripheral blood and T-cell chimerism dynamics after umbilical cord blood transplantation supported with haploidentical cells.

Authors:  M Kwon; C Martínez-Laperche; P Balsalobre; D Serrano; J Anguita; J Gayoso; J L Díez-Martín; I Buño
Journal:  Bone Marrow Transplant       Date:  2013-11-11       Impact factor: 5.483

8.  Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia.

Authors:  Andromachi Scaradavou; Claudio G Brunstein; Mary Eapen; Jennifer Le-Rademacher; Juliet N Barker; Nelson Chao; Corey Cutler; Colleen Delaney; Fangyu Kan; Luis Isola; Chatchada Karanes; Mary J Laughlin; John E Wagner; Elizabeth J Shpall
Journal:  Blood       Date:  2012-12-09       Impact factor: 22.113

9.  Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies.

Authors:  Parastoo B Dahi; Jonathan Barone; Sean M Devlin; Courtney Byam; Marissa Lubin; Doris M Ponce; Sergio Giralt; Nancy A Kernan; Andromachi Scaradavou; Susan H Hsu; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2014-01-23       Impact factor: 5.742

10.  Better allele-level matching improves transplant-related mortality after double cord blood transplantation.

Authors:  Betül Oran; Kai Cao; Rima M Saliba; Katayoun Rezvani; Marcos de Lima; Sairah Ahmed; Chitra M Hosing; Uday R Popat; Yudith Carmazzi; Partow Kebriaei; Yago Nieto; Gabriela Rondon; Dana Willis; Nina Shah; Simrit Parmar; Amanda Olson; Brandt Moore; David Marin; Rohtesh Mehta; Marcelo Fernández-Viña; Richard E Champlin; Elizabeth J Shpall
Journal:  Haematologica       Date:  2015-08-06       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.